EA201890386A1 - Ингибитор мутированной изоцитратдегидрогеназы idh1 r132h - Google Patents
Ингибитор мутированной изоцитратдегидрогеназы idh1 r132hInfo
- Publication number
- EA201890386A1 EA201890386A1 EA201890386A EA201890386A EA201890386A1 EA 201890386 A1 EA201890386 A1 EA 201890386A1 EA 201890386 A EA201890386 A EA 201890386A EA 201890386 A EA201890386 A EA 201890386A EA 201890386 A1 EA201890386 A1 EA 201890386A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- isocytratdehydrogenase
- idh1
- muted
- inhibitor
- adduct
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Настоящее изобретение касается аддукта (2E)-бут-2-ендикарбоновой кислоты - 3-(2-{[4-(трифторметокси)фенил]амино}-1-[(1R,5R)-3,3,5-триметилциклогексил]-1H-бензимидазол-5-ил)пропановой кислоты (1:4), способов приготовления этого аддукта, фармацевтических композиций, включающих этот аддукт, а также применения этого аддукта для приготовления медикамента для лечения заболевания.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15178419 | 2015-07-27 | ||
| PCT/EP2016/067477 WO2017016992A1 (en) | 2015-07-27 | 2016-07-22 | Inhibitor of the mutated isocitrate dehydrogenase idh1 r132h |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA201890386A1 true EA201890386A1 (ru) | 2018-08-31 |
Family
ID=53758092
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201890386A EA201890386A1 (ru) | 2015-07-27 | 2016-07-22 | Ингибитор мутированной изоцитратдегидрогеназы idh1 r132h |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US10344004B2 (ru) |
| EP (1) | EP3328837B1 (ru) |
| JP (1) | JP6804516B2 (ru) |
| KR (1) | KR20180030789A (ru) |
| CN (1) | CN107810181B (ru) |
| AR (1) | AR105493A1 (ru) |
| AU (1) | AU2016300980B2 (ru) |
| BR (1) | BR112018001534A2 (ru) |
| CA (1) | CA2993473A1 (ru) |
| CL (1) | CL2018000249A1 (ru) |
| CO (1) | CO2018000793A2 (ru) |
| CR (1) | CR20180053A (ru) |
| CU (1) | CU20180014A7 (ru) |
| DO (1) | DOP2018000027A (ru) |
| EA (1) | EA201890386A1 (ru) |
| EC (1) | ECSP18006465A (ru) |
| ES (1) | ES2860693T3 (ru) |
| HK (1) | HK1252449A1 (ru) |
| IL (1) | IL256024A (ru) |
| MX (1) | MX2018001205A (ru) |
| NI (1) | NI201800014A (ru) |
| PE (1) | PE20181038A1 (ru) |
| SV (1) | SV2018005621A (ru) |
| TN (1) | TN2018000038A1 (ru) |
| TW (1) | TW201708193A (ru) |
| WO (1) | WO2017016992A1 (ru) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA031655B1 (ru) | 2014-02-11 | 2019-02-28 | Байер Фарма Акциенгезельшафт | Бензимидазол-2-амины в качестве ингибиторов midhi |
| WO2015121209A1 (en) | 2014-02-11 | 2015-08-20 | Bayer Pharma Aktiengesellschaft | Benzimidazol-2-amines as midh1 inhibitors |
| US10137110B2 (en) | 2014-10-23 | 2018-11-27 | Bayer Pharma Aktiengesellschaft | 1-cyclohexyl-2-phenylaminobenzimidazoles as mIDH1 inhibitors for the treatment of tumors |
| CA2988356A1 (en) | 2015-06-08 | 2016-12-15 | Bayer Pharma Aktiengesellschaft | N-menthylbenzimidazoles as midh1 inhibitors |
| JP6824952B2 (ja) | 2015-07-07 | 2021-02-03 | ドイチェス クレープスフォルシュングスツェントルム シュティフトゥング デス エッフェントリッヒェン レヒツ | ｍＩＤＨ１阻害剤としての２−アリール−および２−アリールアルキル−ベンズイミダゾール |
| CN108026052B (zh) | 2015-07-16 | 2021-10-08 | 德国癌症研究公共权益基金会 | 作为mIDH1抑制剂的5-羟烷基苯并咪唑类 |
| EP3121166A1 (en) | 2015-07-21 | 2017-01-25 | Bayer Pharma Aktiengesellschaft | Fused imidazoles as midh1 inhibitors |
| TW201718513A (zh) | 2015-07-27 | 2017-06-01 | 拜耳製藥公司 | 製備經取代之３－（２－苯胺－１－環己基－１ｈ－苯并咪唑－５－基）丙酸衍生物之方法 |
| WO2019015672A1 (zh) * | 2017-07-21 | 2019-01-24 | 南京明德新药研发股份有限公司 | 吡啶并咪唑类化合物及其应用 |
| EP3661559A1 (en) | 2017-08-01 | 2020-06-10 | Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts | Combination of midh1 inhibitors and dna hypomethylating agents (hma) |
| CN108948205B (zh) * | 2018-07-13 | 2021-09-28 | 北京金岱生物科技有限公司 | 抗idh1r132h单克隆抗体及其应用 |
| TWI760017B (zh) * | 2019-12-23 | 2022-04-01 | 大陸商昆藥集團股份有限公司 | 一種ｉｄｈ１突變體抑制劑的鹽型、晶型及其製備方法 |
| EP4186525A4 (en) | 2020-07-21 | 2024-04-03 | Daiichi Sankyo Co Ltd | COMBINATION DRUG OF TEMOZOLOMIDE AND MUTATED IDH1 ENZYME INHIBITOR |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2445345B1 (en) * | 2009-06-23 | 2014-08-27 | The Translational Genomics Research Institute | Benzamide derivatives |
| JP5808818B2 (ja) * | 2010-11-25 | 2015-11-10 | ラツィオファーム・ゲーエムベーハー | アファチニブの新規塩及び多形形態 |
| KR20140069235A (ko) * | 2011-09-27 | 2014-06-09 | 노파르티스 아게 | 돌연변이체 idh의 억제제로서의 3-피리미딘-4-일-옥사졸리딘-2-온 |
| WO2015121209A1 (en) | 2014-02-11 | 2015-08-20 | Bayer Pharma Aktiengesellschaft | Benzimidazol-2-amines as midh1 inhibitors |
| EA031655B1 (ru) * | 2014-02-11 | 2019-02-28 | Байер Фарма Акциенгезельшафт | Бензимидазол-2-амины в качестве ингибиторов midhi |
| US10137110B2 (en) * | 2014-10-23 | 2018-11-27 | Bayer Pharma Aktiengesellschaft | 1-cyclohexyl-2-phenylaminobenzimidazoles as mIDH1 inhibitors for the treatment of tumors |
| CN107108522B (zh) * | 2014-10-23 | 2020-12-01 | 德国癌症研究中心 | 作为mIDH1抑制剂的苯并咪唑-2-胺 |
| CA2988356A1 (en) * | 2015-06-08 | 2016-12-15 | Bayer Pharma Aktiengesellschaft | N-menthylbenzimidazoles as midh1 inhibitors |
| JP6824952B2 (ja) | 2015-07-07 | 2021-02-03 | ドイチェス クレープスフォルシュングスツェントルム シュティフトゥング デス エッフェントリッヒェン レヒツ | ｍＩＤＨ１阻害剤としての２−アリール−および２−アリールアルキル−ベンズイミダゾール |
| CN108026052B (zh) | 2015-07-16 | 2021-10-08 | 德国癌症研究公共权益基金会 | 作为mIDH1抑制剂的5-羟烷基苯并咪唑类 |
| EP3121166A1 (en) * | 2015-07-21 | 2017-01-25 | Bayer Pharma Aktiengesellschaft | Fused imidazoles as midh1 inhibitors |
| TW201718513A (zh) | 2015-07-27 | 2017-06-01 | 拜耳製藥公司 | 製備經取代之３－（２－苯胺－１－環己基－１ｈ－苯并咪唑－５－基）丙酸衍生物之方法 |
-
2016
- 2016-07-14 TW TW105122262A patent/TW201708193A/zh unknown
- 2016-07-22 WO PCT/EP2016/067477 patent/WO2017016992A1/en active Application Filing
- 2016-07-22 EP EP16741332.7A patent/EP3328837B1/en active Active
- 2016-07-22 ES ES16741332T patent/ES2860693T3/es active Active
- 2016-07-22 JP JP2018504187A patent/JP6804516B2/ja active Active
- 2016-07-22 US US15/748,014 patent/US10344004B2/en not_active Expired - Fee Related
- 2016-07-22 KR KR1020177036977A patent/KR20180030789A/ko unknown
- 2016-07-22 EA EA201890386A patent/EA201890386A1/ru unknown
- 2016-07-22 BR BR112018001534A patent/BR112018001534A2/pt not_active Application Discontinuation
- 2016-07-22 CR CR20180053A patent/CR20180053A/es unknown
- 2016-07-22 PE PE2018000133A patent/PE20181038A1/es unknown
- 2016-07-22 AU AU2016300980A patent/AU2016300980B2/en not_active Ceased
- 2016-07-22 CU CUP2018000014A patent/CU20180014A7/xx unknown
- 2016-07-22 CA CA2993473A patent/CA2993473A1/en not_active Abandoned
- 2016-07-22 CN CN201680038633.9A patent/CN107810181B/zh active Active
- 2016-07-22 TN TNP/2018/000038A patent/TN2018000038A1/en unknown
- 2016-07-22 MX MX2018001205A patent/MX2018001205A/es unknown
- 2016-07-27 AR ARP160102274A patent/AR105493A1/es unknown
-
2017
- 2017-11-30 IL IL256024A patent/IL256024A/en unknown
-
2018
- 2018-01-26 DO DO2018000027A patent/DOP2018000027A/es unknown
- 2018-01-26 NI NI201800014A patent/NI201800014A/es unknown
- 2018-01-26 EC ECIEPI20186465A patent/ECSP18006465A/es unknown
- 2018-01-26 CO CONC2018/0000793A patent/CO2018000793A2/es unknown
- 2018-01-26 CL CL2018000249A patent/CL2018000249A1/es unknown
- 2018-01-26 SV SV2018005621A patent/SV2018005621A/es unknown
- 2018-09-13 HK HK18111750.7A patent/HK1252449A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN107810181B (zh) | 2021-06-22 |
| JP2018521095A (ja) | 2018-08-02 |
| CR20180053A (es) | 2018-03-20 |
| NI201800014A (es) | 2018-09-06 |
| TW201708193A (zh) | 2017-03-01 |
| US10344004B2 (en) | 2019-07-09 |
| ES2860693T3 (es) | 2021-10-05 |
| MX2018001205A (es) | 2018-04-24 |
| CU20180014A7 (es) | 2018-06-05 |
| WO2017016992A1 (en) | 2017-02-02 |
| CL2018000249A1 (es) | 2018-07-06 |
| AU2016300980B2 (en) | 2020-12-24 |
| EP3328837B1 (en) | 2021-01-06 |
| EP3328837A1 (en) | 2018-06-06 |
| CA2993473A1 (en) | 2017-02-02 |
| ECSP18006465A (es) | 2018-04-30 |
| CN107810181A (zh) | 2018-03-16 |
| BR112018001534A2 (pt) | 2018-09-11 |
| SV2018005621A (es) | 2018-12-05 |
| CO2018000793A2 (es) | 2018-05-10 |
| US20180222870A1 (en) | 2018-08-09 |
| HK1252449A1 (zh) | 2019-05-24 |
| AU2016300980A1 (en) | 2017-12-21 |
| TN2018000038A1 (en) | 2019-07-08 |
| DOP2018000027A (es) | 2018-02-28 |
| IL256024A (en) | 2018-01-31 |
| AR105493A1 (es) | 2017-10-11 |
| JP6804516B2 (ja) | 2020-12-23 |
| PE20181038A1 (es) | 2018-07-03 |
| KR20180030789A (ko) | 2018-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201890386A1 (ru) | Ингибитор мутированной изоцитратдегидрогеназы idh1 r132h | |
| EA201891057A1 (ru) | Композиции и способы для ингибирования активности аргиназы | |
| EA201691134A1 (ru) | Новые ингибиторы глутаминазы | |
| EA201691803A1 (ru) | Ингибиторы калликреина плазмы человека | |
| EA201792354A1 (ru) | Композиции обетихолевой кислоты и способы применения | |
| EA201690199A1 (ru) | Лекарственное средство для лечения неалкогольной жировой болезни печени | |
| EA201791576A1 (ru) | Ингибитор jak | |
| MA42032A (fr) | Acides 3-aryl-4-amido-bicyclo [4,5,0]hydroxamiques en tant qu'inhibiteurs de hdac | |
| EA201691857A1 (ru) | Соединения, применимые в качестве иммуномодуляторов | |
| EA201690753A1 (ru) | Комбинации ингибиторов гистондеацетилазы и иммуномодулирующих лекарственных средств | |
| EA201690406A1 (ru) | Селективные ингибиторы grp94 и способы их применения | |
| EA201790576A1 (ru) | Спироциклические ингибиторы катепсина с | |
| PH12016501462A1 (en) | Neprilysin inhibitors | |
| BR112018006866A2 (pt) | compostos agonistas de ppar, composições farmacêuticas e métodos de uso dos mesmos | |
| EA202091731A1 (ru) | Ингибиторы аутотаксина и их применения | |
| EA201890815A1 (ru) | Аминокислотные композиции с модифицированным высвобождением для перорального введения | |
| WO2017019540A3 (en) | Inhibitors of n-linked glycosylation and methods using same | |
| EA201690039A1 (ru) | Ингибиторы rorc2 и способы их применения | |
| EA201791992A1 (ru) | Ингибиторы грелин-o-ацилтрансферазы | |
| EA201792000A1 (ru) | Ингибиторы грелин-o-ацилтрансферазы | |
| EA202191548A1 (ru) | Ингибиторы плазменного калликреина человека | |
| EA201791432A1 (ru) | Композиции на основе пролекарства монометилфумарата | |
| EA201692038A1 (ru) | Способы и композиции для лечения сосудистой мальформации | |
| MX2018010801A (es) | Derivados de acido a-truxilico y composiciones farmaceuticas de los mismos. | |
| EA201692045A1 (ru) | Производное фенантролинфосфоновой кислоты и способ его получения и применения |